NASDAQ:ACLS - Nasdaq - US0545402085 - Common Stock - Currency: USD
62.46
+0.45 (+0.73%)
The current stock price of ACLS is 62.46 USD. In the past month the price increased by 38.49%. In the past year, price decreased by -43.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ASML | ASML HOLDING NV-NY REG SHS | 30.09 | 294.88B | ||
AMAT | APPLIED MATERIALS INC | 17.99 | 134.65B | ||
LRCX | LAM RESEARCH CORP | 23.28 | 107.82B | ||
KLAC | KLA CORP | 25.88 | 105.02B | ||
TER | TERADYNE INC | 23.53 | 13.09B | ||
ENTG | ENTEGRIS INC | 25.51 | 11.54B | ||
ENPH | ENPHASE ENERGY INC | 18.16 | 6.43B | ||
MKSI | MKS INC | 12.6 | 6.04B | ||
NVMI | NOVA LTD | 25.28 | 5.53B | ||
AMKR | AMKOR TECHNOLOGY INC | 15.14 | 4.79B | ||
ONTO | ONTO INNOVATION INC | 17.12 | 4.75B | ||
CAMT | CAMTEK LTD | 22.15 | 3.00B |
Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. The company is headquartered in Beverly, Massachusetts and currently employs 1,524 full-time employees. The company went IPO on 2000-07-11. The firm is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the critical and enabling steps in the IC manufacturing process. Its ion implantation products include high current ion implant, high energy ion implant and medium current ion implant. The firm's Purion H, Purion Dragon, Purion H200, and GSD/E2 Ovation spot beam, high current systems cover all traditional high current requirements as well as those associated with emerging and future devices. Its Purion XE, EXE, and other Purion high energy systems combine its production-proven RF Linac high energy, spot beam technology with the Purion platform wafer handling system. Its medium current ion implant products include its Purion M Si and SiC medium current systems. The company also offers its customers aftermarket service and support.
AXCELIS TECHNOLOGIES INC
108 Cherry Hill Dr
Beverly MASSACHUSETTS 01915 US
CEO: Mary G. Puma
Employees: 1524
Phone: 19782324001
The current stock price of ACLS is 62.46 USD. The price increased by 0.73% in the last trading session.
The exchange symbol of AXCELIS TECHNOLOGIES INC is ACLS and it is listed on the Nasdaq exchange.
ACLS stock is listed on the Nasdaq exchange.
14 analysts have analysed ACLS and the average price target is 85.39 USD. This implies a price increase of 36.71% is expected in the next year compared to the current price of 62.46. Check the AXCELIS TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AXCELIS TECHNOLOGIES INC (ACLS) has a market capitalization of 2.01B USD. This makes ACLS a Mid Cap stock.
AXCELIS TECHNOLOGIES INC (ACLS) currently has 1524 employees.
AXCELIS TECHNOLOGIES INC (ACLS) has a support level at 62.45 and a resistance level at 62.47. Check the full technical report for a detailed analysis of ACLS support and resistance levels.
The Revenue of AXCELIS TECHNOLOGIES INC (ACLS) is expected to decline by -25.43% in the next year. Check the estimates tab for more information on the ACLS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ACLS does not pay a dividend.
AXCELIS TECHNOLOGIES INC (ACLS) will report earnings on 2025-07-29, after the market close.
The PE ratio for AXCELIS TECHNOLOGIES INC (ACLS) is 11.11. This is based on the reported non-GAAP earnings per share of 5.62 and the current share price of 62.46 USD. Check the full fundamental report for a full analysis of the valuation metrics for ACLS.
The outstanding short interest for AXCELIS TECHNOLOGIES INC (ACLS) is 17.64% of its float. Check the ownership tab for more information on the ACLS short interest.
ChartMill assigns a technical rating of 4 / 10 to ACLS. When comparing the yearly performance of all stocks, ACLS is a bad performer in the overall market: 82.93% of all stocks are doing better.
ChartMill assigns a fundamental rating of 7 / 10 to ACLS. ACLS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months ACLS reported a non-GAAP Earnings per Share(EPS) of 5.62. The EPS decreased by -25.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.58% | ||
ROA | 13.28% | ||
ROE | 17.33% | ||
Debt/Equity | 0.04 |
ChartMill assigns a Buy % Consensus number of 73% to ACLS. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of -45.21% and a revenue growth -25.43% for ACLS